S. Expósito Vizcaíno

Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine

Juan Antonio Carrillo, Angustias G. Herráiz, Sara Ramos et al. · Journal of Clinical Psychopharmacology · 2003 · 179 citations

Medicine, Pharmacokinetics, Pharmacology +16

Differences in CYP3A5*3 Genotype Distribution and Combinations With Other Polymorphisms Between Spaniards and Other Caucasian Populations

Guillermo Gervasini, S. Expósito Vizcaíno, Carolina Gasiba et al. · Therapeutic Drug Monitoring · 2005 · 51 citations

Life Sciences, Genetics, Pharmacology +16

The effect of <i>CYP2J2, CYP3A4</i>, <i>CYP3A5</i> and the <i>MDR1 ^C3435T</i> polymorphisms and gender on the urinary excretion of the metabolites of the H₁‐receptor antihistamine ebastine: a pilot study

Guillermo Gervasini, S. Expósito Vizcaíno, Juan Antonio Carrillo et al. · British Journal of Clinical Pharmacology · 2006 · 19 citations · Full text

Veterinary Medicine, Pharmacokinetics, Pharmacology +17

Applicability of an Assay for Routine Monitoring of Highly Variable Concentrations of Olanzapine Based on HPLC with Mass Spectrometric Detection

Guillermo Gervasini, S. Expósito Vizcaíno, Angustias G. Herráiz et al. · Clinical Chemistry · 2003 · 15 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17